Metronidazolo Same Savoma Medicinali

Metronidazole, the active ingredient in Metronidazolo Same Savoma, is a Nitroimidazole presented as a topical formulation for skin use. It is employed to treat certain bacterial skin conditions and inflammatory disorders such as rosacea, acne, and other anaerobic infections of the skin.

GNH USA supplies Metronidazolo Same Savoma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across global markets. The product meets EU standards and is manufactured under strict Good Manufacturing Practices.

Metronidazole is used for topical treatment of skin conditions caused by anaerobic bacteria or inflammation. - Rosacea: reduces inflammatory lesions and erythema associated with the condition. - Bacterial skin infections: eradicates susceptible anaerobic bacteria, promoting lesion healing. - Acne: decreases bacterial colonisation and inflammation, improving lesion count.

Topical metronidazole may cause a range of local and systemic adverse reactions.

Common Side Effects: - Skin irritation: mild redness, itching or burning at the application site. - Dryness: temporary dryness or peeling of the treated skin. - Discoloration: mild hyperpigmentation or hypopigmentation of the area. - Taste disturbance: occasional metallic taste when applied near the mouth.

Serious or Rare Side Effects: - Allergic reaction: rash, swelling, or hives indicating hypersensitivity. - Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement. - Neurological effects: peripheral neuropathy or seizures in rare cases. - Hematologic changes: unexplained anemia or leukopenia.

When using topical metronidazole, several precautions should be observed to ensure safety and effectiveness. - Pregnancy: consult a healthcare professional before use, as safety data are limited. - Breastfeeding: discuss potential risks with a physician, as drug may be excreted in milk. - Skin integrity: avoid application on open wounds or severely damaged skin. - Concomitant therapy: inform the prescriber of other topical or systemic antibiotics being used. - Allergies: discontinue if signs of hypersensitivity appear. - Store below 25°C: keep in the original container, protect from moisture and light.

Metronidazole can interact with other medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Alcohol: may cause a disulfiram‑like reaction with flushing and nausea. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Lithium: may raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely): - Cytochrome P450 inducers (e.g., rifampicin, carbamazepine): may reduce metronidazole concentrations. - Anticonvulsants (e.g., phenytoin): may require dose adjustment. - Oral contraceptives: possible reduction in effectiveness, advise additional contraceptive measures.